NIH-funded research NIH-funded research

Understanding how bacteria communicate and adapt to their environment

Official title: Elucidating Novel Cyclic Nucleotide Signaling Pathways and Physiological Effects in Bacteria

Funded at Pennsylvania State University, the · NIH-11011095 · Data updated 2026-11-12

This study is looking at how bacteria communicate and react to their environment, which is important for their survival and ability to cause infections, and it aims to find new ways to help manage bacterial infections by focusing on a special signaling molecule.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionPennsylvania State University, the
NIH-funded
Lab location1 site (University Park, United States)
Project startFebruary 1, 2025
Project endNovember 30, 2029
Funding year2025
Award (this year)$401,253
NIH project number1R35GM156196-01
Project IDNIH-11011095 on NIH RePORTER

Who could benefit from this research

Could help

Patients suffering from bacterial infections, particularly those caused by E. coli or similar bacteria, would be ideal candidates to benefit from this research.

Less likely to help

Patients with viral infections or non-bacterial diseases may not receive any benefit from this research.

What this research studies

This research investigates how bacteria use signaling pathways to respond to their surroundings, which is crucial for their survival and ability to cause infections. By focusing on a specific type of signaling molecule called 2’,3’-cyclic nucleotide monophosphates (2’,3’-cNMPs), the research aims to uncover the mechanisms that control bacterial behavior, including their growth and resistance to stress. The team will employ various laboratory techniques to study these pathways in E. coli and other bacteria, potentially leading to new strategies for managing bacterial infections.

Why it matters

Potential benefit: If successful, this research could lead to innovative treatments for bacterial infections by targeting their communication pathways.

How similar studies have gone: Other research has shown promise in targeting bacterial signaling pathways, suggesting that this approach could lead to significant advancements in treatment.

Where this research is happening

  • Pennsylvania State University, the
    University Park, United States
    Active

Researchers

  • Principal investigator: Weinert, Emily E — Pennsylvania State University, the
  • Study coordinator: Weinert, Emily E

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.